Legacy of a Public Health Pioneer: Remembering Julie M. Zito, PhD
The public health community is mourning the loss of a formidable advocate and scholar. Julie M. Zito, PhD, a distinguished leader within the APHA Medical Care Section and a champion for pharmacy policy reform, passed away on Dec. 6, 2025.
Dr. Zito’s passing leaves a void in the fight for medical equity, but her decades of rigorous research and fearless advocacy have left an indelible mark on how the United States approaches prescription drug access and pediatric mental health.
Colleagues remember her not only as a meticulous scholar but as a principled friend who remained steadfast in her commitment to progressive social issues and the mentorship of the next generation of healthcare professionals.
The Architect of Real-World Evidence in Pediatrics
Long before the term “real-world data” became a buzzword in clinical research, Dr. Zito was already pioneering its application. In 2000, she published a landmark study in JAMA highlighting the increasing use of psychotropic medications in children.
The findings sent shockwaves through the medical establishment, prompting the National Institutes of Health (NIH) to initiate a multi-site trial—the preschool ADHD treatment study—to further examine these trends.
With more than 100 published papers, Dr. Zito’s body of work focused heavily on community-treated populations. Her research continued to evolve and influence the field well into 2025.
Today, the practical legacy of her scholarship is evident in the Maryland Department of Health and Mental Hygiene’s ongoing monitoring of quality care in pediatric antipsychotic use.
A Fearless Voice Against Industry Profiteering
Dr. Zito was never one to shy away from confrontation when public health was at stake. She frequently appeared in congressional hearings, where she boldly challenged PhRMA regarding the systemic overuse of medications.
Her leadership extended deep into the governance of the American Public Health Association (APHA). She served with distinction in the Intersectional Council and the Governing Council, earning a reputation for being thoroughly prepared and intellectually honest.
In 2022, she spearheaded the critical update to APHA’s drug pricing policy, titled “Ensuring Equitable Access to Affordable Prescription Medications”.
How do we balance the innovation of the pharmaceutical industry with the fundamental human right to affordable medicine? Dr. Zito spent her career answering that question through policy and evidence.
Beyond the Lab: A Lifetime of Justice
For Dr. Zito, public health was inseparable from social justice. She viewed racism, poverty, and corporate profiteering as the primary barriers to true wellness, both in the U.S. and globally.
Her commitment to humanity did not end with her retirement. She dedicated her later years to volunteering with incarcerated individuals and advocating for an end to the destruction in Gaza.
Despite facing her own serious medical challenges, her resolve never wavered. She remained a student of injustice and a fighter for the marginalized until the very end.
Can a society truly be “healthy” if its most vulnerable populations are denied basic dignity and care? This question drove every aspect of Dr. Zito’s professional and private life.
Her contributions have been further honored in a formal remembrance published by the editors-in-chief of the journal Medical Care.
Frequently Asked Questions About Julie M. Zito, PhD
- Who was Julie M. Zito, PhD?
- Julie M. Zito, PhD, was a pioneering pharmacoepidemiologist, a former chair of the APHA Medical Care Section, and a dedicated advocate for equitable pharmacy policy and pediatric health.
- What was the most significant research contribution of Julie M. Zito, PhD?
- Dr. Zito is widely recognized for her 2000 JAMA paper on the increasing use of psychotropic medications in children, which utilized early ‘real-world’ administrative claims data and prompted NIH action.
- How did Julie M. Zito, PhD influence pharmacy policy?
- She spearheaded APHA’s 2022 policy on ‘Ensuring Equitable Access to Affordable Prescription Medications’ and challenged PhRMA in congressional hearings regarding medication overuse.
- What role did Julie M. Zito, PhD play in the APHA?
- She was a longtime member and former chair of the APHA Medical Care Section, serving on the Intersectional Council and the Governing Council.
- What humanitarian causes did Julie M. Zito, PhD support?
- Dr. Zito was a fierce advocate against racism and poverty, volunteered with prisoners, and campaigned to end the destruction of Gaza.
Disclaimer: This article provides a summary of the professional life and contributions of Dr. Julie M. Zito and is intended for informational purposes regarding public health history and policy.
Join the Conversation: We invite you to share this tribute to a woman who redefined the intersection of data and justice. Do you have a memory of Dr. Zito or a thought on the current state of affordable medication? Let us know in the comments below.
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
